Streetbeat News

THCX

Investment Managers Series Trust II

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Aurora Cannabis is capitalizing on the global trend towards cannabis legalization, utilizing its EU GMP-certified facilities and expertise in genetics and regulations.

Portfolio Pulse from

March 18, 2025 | 6:30 pm

The U.S. cannabis industry is expanding, with legal sales surpassing $30 billion in 2024 and expected to reach $40 billion by 2025. Potential federal reforms and state legalization efforts are driving interest in marijuana stocks, including volatile penny stocks.

Portfolio Pulse from

March 18, 2025 | 2:15 pm

Investors in marijuana stocks are frustrated due to inconsistent trading patterns and downtrends, largely caused by challenges in passing federal reform and establishing efficient regulations in the USA.

Portfolio Pulse from

March 16, 2025 | 3:00 pm

The Canadian cannabis sector is expanding into the U.S. market, anticipating federal legalization. New U.S. federal reform bills could ease banking restrictions, boosting industry growth. Investors are watching these developments closely as they could impact stock performance.

Portfolio Pulse from

March 13, 2025 | 2:15 pm

UC Asset LP has acquired full ownership of a $3 million cannabis property, previously owning 50% and now acquiring the remaining half for $1.5 million. The property includes office and cultivation space.

Portfolio Pulse from

March 11, 2025 | 4:00 pm

The U.S. cannabis industry is projected to reach $40 billion by 2025, with ancillary companies benefiting from increased demand for cultivation equipment and services. Recent state-level legalization efforts in Pennsylvania and Ohio are adding momentum to federal reform discussions, making ancillary stocks attractive to investors.

Portfolio Pulse from

March 11, 2025 | 2:15 pm

Tilray Medical, a division of Tilray Brands, Inc., has launched Tilray Craft, a new brand focusing on high THC, high terpene genetics in the German medical cannabis market.

Portfolio Pulse from

March 11, 2025 | 11:15 am

The Canadian cannabis sector is evolving with companies expanding operations and establishing strong positions in the U.S. market despite federal restrictions. Some have developed partnerships and strategies for potential future legalization.

Portfolio Pulse from

March 08, 2025 | 8:15 pm

Raw Garden has launched the Sprout™ vape, featuring a Terpene-Safe plastic, marking an innovation in cannabis hardware.

Portfolio Pulse from

March 06, 2025 | 10:00 pm

The U.S. cannabis industry is rapidly growing, with legal sales reaching $34 billion in 2023 and potential to exceed $50 billion by 2028. Federal rescheduling discussions and state legalizations could benefit major companies. Investors should use technical analysis to navigate the volatile market.

Portfolio Pulse from

March 02, 2025 | 4:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.